Frontlight ResearchEarly access
Trial site
Tianjin Medical University Chu Hsien-I Memorial Hospital
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease2 trials
- Type 2 diabetes2 trials
- Obesity1 trial
- Phase
- Phase 21 trial
- Phase 2/31 trial
- Status
- Not yet recruiting3 trials
- Active, not recruiting1 trial
- Completed1 trial
- Lead sponsor
- Liu Hongfang2 trials
- Fujian Shengdi Pharmaceutical Co., Ltd.1 trial
- Novo Nordisk A/S1 trial
- Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.1 trial
Running trials
Not yet recruiting
A Study of HRS-4729 Injection in Participants With Type 2 Diabetes
Not yet recruiting
Not yet recruiting
Active, not recruiting
The Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (ENLIGHT)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease2 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026